TNF and rheumatoid arthritis: Similarly, in both animal models and patients with rheumatoid arthritis or discogenic LBP, TNF-α blocking drugs were shown not only to reverse central pain responses but also to improve disability (Hess et al., 2011; Sainoh et al., 2016).